Hormel Foods Announces Definitive Agreement to Sell its Whole-Bird Turkey Business to Life-Science Innovations

Core Viewpoint - Hormel Foods Corporation has entered into a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations, marking a strategic shift towards more value-added protein offerings while maintaining the JENNIE-O brand as a source of profitable growth [1] Group 1: Transaction Details - The transaction is expected to close by the end of the second quarter of fiscal 2026, subject to customary closing conditions [1] - Life-Science Innovations will acquire assets including the Melrose, Minnesota whole-bird production facility, Swanville, Minnesota feed mill, and associated transportation assets [1] - LSI will assume supply contracts with third-party turkey growers dedicated to the whole-bird business and provide co-manufacturing services to Hormel Foods through the end of fiscal 2026 [1] Group 2: Strategic Implications - Hormel Foods aims to reduce exposure to volatile, commodity-driven businesses and focus on expanding its value-added protein portfolio [1] - The sale is seen as an important step in Hormel's evolution, allowing for a more focused turkey portfolio and strengthening the value-added aspects of the JENNIE-O business [1] - Hormel expects the sale to have a minimal impact on its adjusted fiscal 2026 financial results, with further details to be discussed in the upcoming earnings call [1] Group 3: Company Background - Hormel Foods Corporation is a global branded food company with over $12 billion in annual revenue, known for brands such as PLANTERS®, SKIPPY®, SPAM®, and JENNIE-O® [1] - The company is a member of the S&P 500 Index and has received numerous accolades for corporate responsibility and community service efforts [1] - Life-Science Innovations has over 80 years of experience in the turkey industry, enhancing its capability to manage the acquired business effectively [1]

Hormel Foods Announces Definitive Agreement to Sell its Whole-Bird Turkey Business to Life-Science Innovations - Reportify